Top 10 Emerging Travel Vaccine Firms in Brazil 2026

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The global travel vaccine market is seeing significant growth, driven by an increase in international travel and a rising awareness of the importance of vaccination. In Brazil, the market for travel vaccines is also expanding rapidly, with a number of emerging firms making a mark in the industry. According to recent statistics, the market for travel vaccines in Brazil is expected to reach $X million by 2026, with a compound annual growth rate of X%.

Top 10 Emerging Travel Vaccine Firms in Brazil 2026:

1. Bio-Manguinhos/Fiocruz
Bio-Manguinhos/Fiocruz is a leading Brazilian pharmaceutical company specializing in the production of vaccines. They have a strong presence in the travel vaccine market, with a market share of X%. Their high-quality vaccines are widely recognized for their effectiveness and affordability.

2. Instituto Butantan
Instituto Butantan is another key player in the Brazilian travel vaccine market, known for its innovative research and development efforts. They hold a X% market share and are expected to grow significantly in the coming years.

3. Aché Laboratórios Farmacêuticos
Aché Laboratórios Farmacêuticos is a major pharmaceutical company in Brazil that has been expanding its portfolio to include travel vaccines. With a market share of X%, they are poised to become a prominent player in the industry.

4. Cristália Produtos Químicos Farmacêuticos
Cristália Produtos Químicos Farmacêuticos is a rapidly growing firm in the travel vaccine sector, known for its commitment to quality and innovation. They currently hold a X% market share and are expected to see further growth in the near future.

5. EMS
EMS is a well-established pharmaceutical company in Brazil that has recently entered the travel vaccine market. With a market share of X%, they are quickly gaining traction and are projected to be a top player in the industry.

6. Farmanguinhos/Fiocruz
Farmanguinhos/Fiocruz is a division of Fiocruz dedicated to the production of vaccines, including travel vaccines. With a X% market share, they are a key player in the Brazilian market and are expected to see continued growth in the coming years.

7. Libbs Farmacêutica
Libbs Farmacêutica is a leading pharmaceutical company in Brazil that has recently expanded its offerings to include travel vaccines. With a X% market share, they are making a significant impact in the industry and are poised for further growth.

8. Eurofarma Laboratórios
Eurofarma Laboratórios is a prominent pharmaceutical company in Brazil that has been investing in the development of travel vaccines. With a X% market share, they are gaining recognition for their high-quality products and are expected to see strong growth in the future.

9. Biolab Sanus Farmacêutica
Biolab Sanus Farmacêutica is a growing player in the travel vaccine market in Brazil, known for its focus on research and development. With a X% market share, they are on track to become a major competitor in the industry.

10. Mantecorp Indústria Química e Farmacêutica
Mantecorp Indústria Química e Farmacêutica is a well-known pharmaceutical company in Brazil that has recently expanded its product line to include travel vaccines. With a X% market share, they are expected to see significant growth in the coming years.

Insights:

The travel vaccine market in Brazil is poised for significant growth in the coming years, driven by factors such as increasing international travel and a growing awareness of the importance of vaccination. With a projected market size of $X million by 2026, the industry presents lucrative opportunities for both established firms and emerging players. Companies that focus on innovation, quality, and affordability are likely to see the most success in this competitive market. Additionally, partnerships with international organizations and investments in research and development will be key to staying competitive in the rapidly evolving landscape of travel vaccines.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →